Physician profile
Eric J Radcliffe
NPI 1386627743
$286.94
in general payments reported to CMS, 2019-2025
10 companies · $24.41 in 2025
The $24.41 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.59 · 2021: $32.32 · 2022: $65.18 · 2023: $14.72 · 2024: $80.72 · 2025: $24.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $41.80 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.97 | 2023-2024 | Eliquis |
| Novo Nordisk INC | $36.39 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $32.81 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $31.93 | 2019-2022 | |
| Eisai INC. | $26.67 | 2024 | |
| Allergan, INC. | $25.76 | 2019 | |
| Abbott Laboratories | $24.41 | 2025 | Amplatzer Amulet |
| Abbvie INC. | $17.77 | 2024 | |
| Glaxosmithkline, LLC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Radcliffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.